Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study

SIMPLE SUMMARY: Trifluridine/tipiracil (TAS-102) is an oral chemotherapy approved for the treatment of metastatic colorectal cancer (mCRC). Efficacy and safety of TAS-102 was shown in phase II-III clinical trials and in several real-life studies but elderly and other special subgroups are underrepre...

Descripción completa

Detalles Bibliográficos
Autores principales: Conti, Matteo, Bolzacchini, Elena, Luchena, Giovanna, Bertu’, Lorenza, Tagliabue, Paola, Aglione, Stefania, Ardizzoia, Antonio, Arnoffi, Jessica, Guida, Francesco Maria, Bertolini, Alessandro, Pastorini, Alessandro, Duro, Maria, Bettega, Donato, Roda’, Giovambattista, Artale, Salvatore, Squizzato, Alessandro, Giordano, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340604/
https://www.ncbi.nlm.nih.gov/pubmed/37444575
http://dx.doi.org/10.3390/cancers15133465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340604/
https://www.ncbi.nlm.nih.gov/pubmed/37444575
http://dx.doi.org/10.3390/cancers15133465

Ejemplares similares